WHO ICTRP trial
Sugammadex for prevention of postoperative pulmonary complications
ISRCTN15109717 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN15109717 |
|---|---|
| Public title | Sugammadex for prevention of postoperative pulmonary complications |
| Scientific title | Sugammadex for prevention of postoperative pulmonary complications |
| Primary sponsor | Belfast Health and Social Care Trust |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | England;Northern Ireland;Scotland;United Kingdom;Wales |
| Conditions | Elective or emergency major abdominal or non-cardiac thoracic surgery Surgery |
| Interventions | This randomised trial will compare the effectiveness of two drugs for the reversal of neuromuscular blocking agents at the end of anaesthesia to prevent postoperative pulmonary complications and thus recovery after major surgery… |
| Registration date | Dec 21, 2022 |
| Target size | 2500 |
| Secondary IDs | Nil known;Nil known;21021JS-AS, IRAS 1006043, CPMS 54659 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: